US 12,122,825

Application 17/438,684 · Granted Oct 22, 2024

Nucleic acid molecule encoding, and method of producing, a recombinant anti-tumor necrosis factor (tnf) antibody

Estimated expiration

February 10, 2041

14y 85d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
  • Could not fetch continuity data for application PCTIB2020051635: Resource not found (404)
Earliest effective filing
Feb 26, 2020
+ 20 years
Feb 26, 2040
PTA +350d
Feb 10, 2041
TD applied
Feb 10, 2041
Final
Feb 10, 2041

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).

Calculation details

Base term

Filing date
September 13, 2021
Earliest effective filing
February 26, 2020
Issue date
October 22, 2024
PTA
+350 days
Base expiry (before PTA)
February 26, 2040

February 26, 2020 + 20 years = February 26, 2040 + 350 PTA days = February 10, 2041

  • National stage entry of application PCTIB2020051635, filed Feb 26, 2020
  • PRO62/818,316 — Provisional — not used for base term

Terminal disclaimers

TD approved1 approved, 1 filed

TD caps expiration to February 10, 2041

  • US 12,122,825· Application 17/438,684(from application 17/438,684)Capping patent

    Nucleic acid molecule encoding, and method of producing, a recombinant anti-tumor necrosis factor (tnf) antibody

    Filing date
    Sep 13, 2021
    Earliest effective filing
    Feb 26, 2020
    Issue date
    Oct 22, 2024
    PTA
    +350 days
    Calculated expiration
    Feb 10, 2041

    National stage entry of PCTIB2020051635, filed Feb 26, 2020

    Feb 26, 2020 + 20y + 350d PTA = Feb 10, 2041

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 17/438,684 · US 12,122,825

PatentReply compiles the prosecution history behind US 12,122,825: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US12122825

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.